PanGenomic Health, Inc. Class A (TSE:NARA) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PanGenomic Health Inc. has announced that the British Columbia Securities Commission issued a management cease trade order due to the company’s delay in filing its annual financial statements. The company, which is working with its auditors, expects to complete the filings by June 28, 2024, after securing debt financing to settle outstanding auditor fees. Meanwhile, the company’s CEO and CFO are restricted from trading company securities, although regular shareholders remain unaffected.
For further insights into TSE:NARA stock, check out TipRanks’ Stock Analysis page.